Catalog |
name |
Description |
price |
R-R-1453 |
Ivarmacitinib CAS No.1445987-21-2 |
Ivarmacitinib (SHR0302)/CAS No.1445987-21-2 is a potent and orally active all members of the JAK family inhibitor, particularly JAK1. The selectivity of Ivarmacitinib for JAK1 is >10-fold for JAK2, 77-fold for JAK3, 420-fold for Tyk2. Ivarmacitinib inhibits JAK1-STAT3 phosphorylation and induces the apoptosis of hepatic stellate cells. Ivarmacitinib has anti-proliferative and anti-inflammatory effects. |
price> |
R-R-1454 |
C2 Ceramide CAS No.3102-57-6 |
C2 Ceramide (Ceramide 2)/CAS No.3102-57-6 is the main lipid of the stratum corneum and a protein phosphatase 1 (PP1) activator. C2 Ceramide activates PP2A and ceramide-activated protein phosphatase (CAPP). C2 Ceramide induces cells differentiation, autophagy and apoptosis, inhibits mitochondrial respiratory chain complex III. C2 Ceramide is also a skin conditioning agent that protects the epidermal barrier from water loss. |
price> |
R-R-1455 |
Pyridinium bisretinoid A2E TFA CAS No.1821308-73-9 |
Pyridinium bisretinoid A2E (A2E) TFA/CAS No.1821308-73-9 is a fluorophore that can be isolated from lipofuscin in the retinal pigment epithelium (RPE). Pyridinium bisretinoid A2E TFA is an initiator of blue-light-induced apoptosis. Photoactivation of Pyridinium bisretinoid A2E TFA mediates autophagy and the production of reactive oxygen species. Pyridinium bisretinoid A2E TFA can be used in the study of retinal degenerative diseases. |
price> |
R-R-1456 |
5-Fluorouracil-15N2 CAS No.68941-95-7 |
5-Fluorouracil-15N2/CAS No.68941-95-7 is the 15N-labeled 5-Fluorouracil. 5-Fluorouracil (5-FU) is an analogue of uracil and a potent antitumor agent. 5-Fluorouracil affects pyrimidine synthesis by inhibiting thymidylate synthetase thus depleting intracellular dTTP pools. 5-Fluorouracil induces apoptosis and can be used as a chemical sensitizer. 5-Fluorouracil also inhibits HIV. |
price> |
R-R-1457 |
Alemtuzumab CAS No.216503-57-0 |
Alemtuzumab (Campath-IH)/CAS No.216503-57-0 is a humanized monoclonal antibody against CD52. Alemtuzumab does not cross-react with murine CD52. Alemtuzumab selectively targets the CD52 antigen to induce profound lymphocyte depletion, followed by recovery of T and B cells with regulatory phenotypes. Alemtuzumab is capable of complement-dependent cytotoxicity and antibody-dependent cell-mediated cytotoxicity (ADCC), as well as induction of apoptosis. Alemtuzumab has the potential for B-cell chronic lymphocytic leukaemia research. |
price> |
R-R-1458 |
Liensinine CAS No.2586-96-1 |
Liensinine/CAS No.2586-96-1 is an autophagy/mitophagy inhibitor. Liensinine, a major isoquinoline alkaloid, extracted from the seed embryo of Nelumbo nucifera Gaertn, has a wide range of biological activities, including anti-arrhythmias, anti-hypertension, anti-pulmonary fibrosis, relaxation on vascular smooth muscle, etc. |
price> |
R-R-1459 |
DuP-697 CAS No.88149-94-4 |
DuP-697/CAS No.88149-94-4 is a member of the vicinal diaryl heterocycles and a potent, irreversible, selective and orally active COX-2 inhibitor (IC50 of 10 nM and 800 nM for human COX-2 and COX-1, respectively). DuP-697 exerts antiproliferative (IC50 of 42.8 nM), antiangiogenic and apoptotic effects on HT29 colorectal cancer cells. DuP-697 inhibits prostaglandin synthesis and has anti-inflammatory, anticancer and antipyretic effects. |
price> |
R-R-1460 |
Pexidartinib hydrochloride CAS No.2040295-03-0 |
Pexidartinib hydrochloride (PLX-3397 hydrochloride)/CAS No.2040295-03-0 is a potent, orally active, selective, and ATP-competitive colony stimulating factor 1 receptor (CSF1R or M-CSFR) and c-Kit inhibitor, with IC50s of 20 and 10 nM, respectively. Pexidartinib hydrochloride exhibits 10- to 100-fold selectivity for c-Kit and CSF1R over other related kinases. Pexidartinib hydrochloride induces cell apoptosis and has anti-cancer activity. |
price> |
R-R-1461 |
ENMD-1068 hydrochloride CAS No.2703451-51-6 |
ENMD-1068 hydrochloride/CAS No.2703451-51-6 is a selective protease-activated receptor 2 (PAR2) antagonist. ENMD-1068 hydrochloride reduces hepatic stellate cell activation and collagen expression by inhibiting TGF-β1/Smad signaling. ENMD-1068 hydrochloride also inhibits the proliferation of endometrial cells and induces apoptosis of epithelial cells in the lesion. ENMD-1068 hydrochloride can be used in the study of endometriosis and liver fibrosis. |
price> |
R-R-1462 |
5-NIdR CAS No.191421-10-0 |
5-NIdR (1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole)/CAS No.191421-10-0, an artificial nucleoside, exhibits the ability to inhibit the replication of DNA lesions generated by Temozolomide (HY-17364). 5-NIdR induces cancer cells apoptosis and arrests cell cycle at G0 phase. 5-NIdR enhances Temozolomide anti-tumor efficacy in murine glioblastoma model. |
price> |